Our present results demonstrate that a decrease in NKX2-3 gene expression level can profoundly affect the signaling pathways relevant to the pathogenesis and progression of IBD such as the EDN1 and VEGF signaling and PI3K/AKT-eNOS pathways. Here, AKT1 is linked to inflammatory bowel disease.